Specialised Therapeutics has launched NERLYNX, an oral breast cancer therapy approved for reducing cancer recurrence and improving disease-free survival in early and advanced HER2-positive breast cancer patients in Thailand.
Company Information
Company
Specialised Therapeutics
Location
Thailand
About
Specialised Therapeutics (ST) is an independent pharmaceutical company committed to developing and providing innovative therapies for patients with rare diseases. The company focuses on enhancing access to specialized medications and technologies to improve patient outcomes. ST operates with a dedicated team that understands local healthcare landscapes and works closely with health authorities and oncologists. Its recent approval of the NERLYNX breast cancer therapy marks a significant milestone in addressing the needs of breast cancer patients in Thailand.
Fundz sees it the moment Specialised Therapeutics ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ThailandBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical